Pharmafile Logo
Pharmafocus logo
Advanced Search
nhs_parliament_2_4

Public dissatisfaction with NHS found to be growing, says BMA

June 26, 2017
Medical Communications, Sales and Marketing BMA, NHS

The British Medical Association has revealed that a poll, conducted by British doctors, shows that levels of public dissatisfaction with …

News
novo_nordisk_flag

Promising Phase 2 obesity data for Novo’s diabetes drug

June 26, 2017
Research and Development, Sales and Marketing Novo Nordisk

Novo Nordisk is hopeful about the prospects of its diabetes drug semaglutide as a treatment for obesity after it produced …

News

Astellas receives further year suspension from ABPI

June 26, 2017
Medical Communications, Sales and Marketing ABPI, Astellas

The Association of the British Pharmaceutical Industry (ABPI) has announced that it has taken the unusual step of extending the …

News

Woodley Equipment Attending Outsourcing in Clinical Trials UK & Ireland 2017

June 23, 2017

Woodley Equipment is attending Outsourcing in Clinical Trials UK and Ireland Conference taking place at the Royal Garden Hotel, London …

News
Press release

Pfizer’s biosimilar gets a second knock-back from FDA

June 23, 2017
Medical Communications, Sales and Marketing Amgen, Epogen, FDA, Pfizer

Pfizer has been dealt a stinging blow by the FDA, after it received a second complete response letter from the …

News
novartis_outside_1

Novartis lung cancer combo receives FDA approval

June 23, 2017
Medical Communications, Sales and Marketing NSCLC, Novartis

Novartis has revealed that its drug Tafinlar (dabrafenib) has received approval from the FDA for use in combination with Mekinist …

News
needle-1291170_960_720

HIV cases in gay men fall for the first time in England

June 23, 2017
Medical Communications HIV, PrEP

For the first time in English history, new diagnoses of HIV have fallen across the country – the drop was …

News
shutterstock_187433765

Rare cancers through the looking glass

June 23, 2017
Medical Communications, Research and Development pharmafile, rare cancer

Rare cancers are not so rare after all. According to the organisation Rare Cancer Europe more than 4.3 million people …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

June 23, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

We’re officially into summer, and the weekend is here. This week saw a number of stories that piqued the attention …

News
shutterstock_311949818

Immune system attacks the brain in Alzheimer’s, study suggests

June 22, 2017
Research and Development Alzheimer's

New research has identified direct evidence that the body’s immune system attacks the brain in Parkinson’s disease, seemingly confirming a …

News
ovarian_cancer

Risk estimate produced from long-term BRCA gene study

June 22, 2017
Research and Development BRCA, Cancer Research UK, University of Cambridge

A new study funded by Cancer Research UK and carried out by the University of Cambridge has identified the ages …

News
shutterstock_3

New research unlocks the key to slowing cancer metastasis

June 22, 2017
Research and Development Cancer, metastasis

Stemming from a theory she developed as a sophomore at John Hopkins University in Maryland, Hasini Jayatilaka and a team …

News
novartis_headquarters

Novartis pulls off surprise success in cardiovascular risk

June 22, 2017
Research and Development, Sales and Marketing Novartis

Novartis has posted positive news from the Cantos clinical trial study that saw its drug, Canakinumab, pull of a surprise …

News

FDA’s Gottlieb draws those ‘gaming’ system into pricing debate

June 22, 2017
Medical Communications, Sales and Marketing Drug pricing, FDA, Trump

President Trump spoke often of how pharmaceutical companies were ‘getting away with murder’, in regards to drug pricing, and now …

News
fda2outsideweb

FDA locks down import from 3 Indian IPCA facilities

June 21, 2017
Manufacturing and Production, Research and Development FDA, India, Ipca

More drama in the Indian pharma sector as the FDA announces it has enforced a ban on the import of …

News
shire_image

10 years later, Shire gains FDA approval for ADHD drug

June 21, 2017
Research and Development, Sales and Marketing ADHD, Shire

Shire has revealed that the FDA has approved its long-acting and interestingly named ADHD drug, Mydayis. The approval comes more …

News

Immune system exhaustion associated with irritable bowel syndrome

June 21, 2017
Research and Development IBS, irritable bowel syndrome, t cells

Researchers from the University of Adelaide have linked a specific type of irritable bowel syndrome with the exhaustion of the …

News
novo_nordisk_flag

FDA backs Novo’s diabetes drug for cardiovascular efficacy

June 21, 2017
Research and Development Novo Nordisk, Victoza

Good news for Novo Nordisk as the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) of the FDA recommends that data …

News
microscope-275984_960_720

FDA-approved drugs in combination could provide new antibiotics

June 21, 2017
Research and Development Antibiotics, FDA, antibiotic resistance

Research emerging from the University of Utah Health has built on knowledge that drugs used in combination can be more …

News

Novartis receives positive news in eye drug P3 studies

June 20, 2017
Manufacturing and Production, Research and Development Eylea, Novartis, Regeneron

Novartis has achieved positive feedback from its two Phase 3 studies into its eye drug RTH258 (brolucizumab), which found it …

News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026